2026 congress presentations and educational materials

2026 congress presentations and educational materials
2026 congress presentations and educational materials

Gastric and gastroesophageal cancers

Determinants of biomarker testing and treatment selection in gastric or gastroesophageal junction adenocarcinoma

Rupali Fuldeore et al.

Phase 3 LUCERNA trial in progress: zolbetuximab + pembrolizumab and chemotherapy in advanced gastric or gastroesophageal junction adenocarcinoma

Kohei Shitara et al.

Phase 2 ILUSTRO trial (cohort 4): zolbetuximab + mFOLFOX6 + nivolumab in advanced gastric or gastroesophageal junction adenocarcinoma 

Kohei Shitara et al.

The impact of proton pump inhibitor exposure on survival outcomes with zolbetuximab

Akihiro Yamada et al.

Pancreatic cancer

Efficacy and safety of ASP3082 in KRAS G12D-mutant pancreatic ductal adenocarcinoma

Anup Kasi et al.

Molecular characterization of CLDN18.2 in pancreatic ductal adenocarcinoma 

Guoqiang Zhang et al.

Phase 1 evaluation of ASP3082 in KRAS G12D-mutant pancreatic ductal adenocarcinoma: Pharmacokinetic and biomarker insights

Wungki Park et al.

Treatment patterns and outcomes in pancreatic ductal adenocarcinoma

Rupali Fuldeore et al.